Who Should Receive CAR-T Cell Therapy for Lymphoma?

• Date :
• 0    
  0

New and Emerging Therapies for Hairy Cell Leukemia

• Date :
• 0    
  0

Case Presentations: Waldenström Macroglobulinemia

• Date :
• 0    
  0

What is New in Waldenström Macroglobulinemia? How I Treat it

• Date :
• 0    
  0

Panel Discussion: Hairy Cell Leukemia

• Date :
• 0    
  0

Epigenetic Therapy for Lymphoma: From the Laboratory to the Clinic

• Date :
• 0    
  0

Follicular Lymphoma Panel Discussion

• Date :
• 0    
  0

Follicular Lymphoma Debate: Chemotherapy no Longer Has a Major Role in the Treatment

• Date :
• 0    
  0

Debate: Watch and Wait in Follicular Lymphoma: Should We Treat Immediately?

• Date :
• 0    
  0

Antibodies in Practice: SLAMF-7, CD38, Bispecific?

• Date :
• 0    
  0

BCMA: Predicting Outcomes and Monitoring MM and CLL

• Date :
• 0    
  0

Panel Discussion: Precision Medicine in Multiple Myeloma

• Date :
• 0    
  0

Myeloma: Use of Novel Imaging Techniques at Presentation, Relapse, and MRD

• Date :
• 0    
  0

Clinical Use of Mass Spectrometry in Measuring Myeloma

• Date :
• 0    
  0

Deep Sequencing in Myeloma: Would it Change Treatment? Does it Really Help?

• Date :
• 0    
  0

Chemotherapy vs Novel Agents in Young CLL Patients: Is There Still a Role for Chemo?

• Date :
• 0    
  0

Panel Discussion on Follicular Lymphoma

• Date :
• 0    
  0

Follicular Lymphoma Debate: Does Chemotherapy Have a Major Role to play?

• Date :
• 0    
  0

Follicular Lymphoma Debate: Watch and Wait or Treat Immediately?

• Date :
• 0    
  0

Chronic Lymphocytic Leukemia: Case Discussions

• Date :
• 0    
  0

Immune Function in CLL: What is Wrong and Why?

• Date :
• 0    
  0

Panel Discussion: 'Next Line Treatment for CLL

• Date :
• 0    
  0

Richter’s: Who will Get, What to Do?

• Date :
• 0    
  0

CLL: Treatment for BTKi Progressors

• Date :
• 0    
  0

NOTCH1: The Clinical and Basic Science Behind it

• Date :
• 0    
  0

Chronic Lymphocytic Leukemia: Update on CAR-T Cells

• Date :
• 0    
  0

Venetoclax Resistance: Mechanisms and Treatment Options

• Date :
• 0    
  0

Panel Discussion: Front-line CLL Treatment

• Date :
• 0    
  0

Combination of Novel Agents in CLL: Is this the Final Answer?

• Date :
• 0    
  0

Novel Agents in Elderly CLL Patients: Should the Approach be Different?

• Date :
• 0    
  0

9ème Journée Nationale Maladies Rares Immuno-Hématologiques - MaRIH 2023

• Date :
• 3380    
  6

International Society on Thrombosis and Haemostasis congress - ISTH 2023

• Date :
• 4963    
  0

The European Hematology Association - EHA 2023

• Date :
• 8092    
  0

MDS - 17th International Congress on Myelodysplastic Syndromes

• Date :
• 12637    
  0

43e congrès annuel de la Société Française d’Hématologie - SFH 2023

• Date :
• 9346    
  7